CF
Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
226
LifeMD
LFMD
$288M
|
SJ
Sarah James
| $6.08 | $15 |
147%
upside
| Overweight |
11 Mar ‘25
6 months ago |
|
227
Oracle
ORCL
$678B
|
TB
Thomas Blakey
| $241.51 | $175 |
28%
downside
| Overweight |
11 Mar ‘25
6 months ago |
|
|
HUT
228
Hut 8
HUT
$3.09B
|
BK
Brett Knoblauch
| $29.30 | $30 |
2%
upside
| Overweight |
7 Mar ‘25
6 months ago |
|
229
BigBear.ai
BBAI
$1.78B
|
JR
Jonathan Ruykhaver
| $4.80 | $6 |
25%
upside
| Overweight |
7 Mar ‘25
6 months ago |
|
230
Elutia
ELUT
$62.7M
|
RO
Ross Osborn
| $1.48 | $8 |
441%
upside
| Overweight |
7 Mar ‘25
6 months ago |
|
|
SNDK
231
Sandisk Corporation Common Stock
SNDK
$10.3B
|
MP
Matthew Prisco
| $70.51 | $60 |
15%
downside
| Overweight |
7 Mar ‘25
6 months ago |
|
232
Western Digital
WDC
$32.8B
|
MP
Matthew Prisco
| $94.54 | $65 |
31%
downside
| Overweight |
7 Mar ‘25
6 months ago |
|
233
Axogen
AXGN
$738M
|
RO
Ross Osborn
| $16.42 | $24 |
46%
upside
| Overweight |
5 Mar ‘25
6 months ago |
|
234
EVgo
EVGO
$525M
|
AS
Andres Sheppard
| $3.90 | $8 |
105%
upside
| Overweight |
5 Mar ‘25
6 months ago |
|
235
ADMA Biologics
ADMA
$3.92B
|
KK
Kristen Kluska
| $16.39 | $25 |
53%
upside
| Overweight |
4 Mar ‘25
6 months ago |
|
236
Stratasys
SSYS
$861M
|
TJ
Troy Jensen
| $10.12 | $15 |
48%
upside
| Overweight |
4 Mar ‘25
6 months ago |
|
237
AST SpaceMobile
ASTS
$9.93B
|
CC
Colin Canfield
| $36.91 | $30 |
19%
downside
| Overweight |
4 Mar ‘25
6 months ago |
|
238
Core Scientific
CORZ
$4.44B
|
BK
Brett Knoblauch
| $14.53 | $21 |
45%
upside
| Overweight |
27 Feb ‘25
6 months ago |
|
239
Acadia Pharmaceuticals
ACAD
$4.28B
|
CD
Charles Duncan
| $24.84 | $28 |
13%
upside
| Overweight |
27 Feb ‘25
6 months ago |
|
240
Jazz Pharmaceuticals
JAZZ
$7.88B
|
CD
Charles Duncan
| $128.53 | $150 |
17%
upside
| Neutral |
26 Feb ‘25
6 months ago |
|
241
DigitalOcean
DOCN
$3.12B
|
TB
Thomas Blakey
| $34.32 | $43 |
25%
upside
| Neutral |
26 Feb ‘25
6 months ago |
|
242
Maplebear
CART
$11.9B
|
DM
Deepak Mathivanan
| $45.47 | $55 |
21%
upside
| Overweight |
26 Feb ‘25
6 months ago |
|
243
Cerus
CERS
$247M
|
RO
Ross Osborn
| $1.29 | $4 |
210%
upside
| Overweight |
21 Feb ‘25
6 months ago |
|
244
Sabre
SABR
$698M
|
DM
Deepak Mathivanan
| $1.77 | $4 |
126%
upside
| Neutral |
21 Feb ‘25
6 months ago |
|
245
FIVE9
FIVN
$2.06B
|
TB
Thomas Blakey
| $26.38 | $57 |
116%
upside
| Overweight |
21 Feb ‘25
6 months ago |
|
246
TripAdvisor
TRIP
$2.06B
|
DM
Deepak Mathivanan
| $17.76 | $13 |
27%
downside
| Underweight |
21 Feb ‘25
6 months ago |
|
247
Krystal Biotech
KRYS
$4.2B
|
JS
Josh Schimmer
| $141.21 | $215 |
52%
upside
| Overweight |
20 Feb ‘25
6 months ago |
|
248
BioMarin Pharmaceuticals
BMRN
$10.7B
|
OB
Olivia Brayer
| $55.69 | $90 |
62%
upside
| Overweight |
20 Feb ‘25
6 months ago |
|
249
Klaviyo
KVYO
$9.96B
|
BK
Brett Knoblauch
| $32.15 | $54 |
68%
upside
| Overweight |
20 Feb ‘25
6 months ago |
|
250
Enovix
ENVX
$1.97B
|
DS
Derek Soderberg
| $9.07 | $30 |
231%
upside
| Overweight |
20 Feb ‘25
6 months ago |
|